Esmolol indications and usage: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Gerald Chi- (talk | contribs) |
||
| Line 11: | Line 11: | ||
===Intraoperative and Postoperative Tachycardia and/or Hypertension=== | ===Intraoperative and Postoperative Tachycardia and/or Hypertension=== | ||
BREVIBLOC (Esmolol Hydrochloride) is indicated for the short-term treatment of tachycardia and [[hypertension]] that occur during induction and [[tracheal intubation]], during surgery, on emergence from anesthesia and in the postoperative period, when in the physician’s judgment such specific intervention is considered indicated. | BREVIBLOC (Esmolol Hydrochloride) is indicated for the short-term treatment of [[tachycardia]] and [[hypertension]] that occur during induction and [[tracheal intubation]], during surgery, on emergence from [[anesthesia]] and in the postoperative period, when in the physician’s judgment such specific intervention is considered indicated. | ||
Use of BREVIBLOC to prevent such events is not recommended.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BREVIBLOC (ESMOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=595cc3d5-1306-4828-aefa-5595219ffd62 | publisher = | date = | accessdate = }}</ref> | Use of BREVIBLOC to prevent such events is not recommended.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BREVIBLOC (ESMOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=595cc3d5-1306-4828-aefa-5595219ffd62 | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} | ||
Revision as of 22:44, 20 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Indications And Usage
Supraventricular Tachycardia or Noncompensatory Sinus Tachycardia
- BREVIBLOC (Esmolol Hydrochloride) is indicated for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutterin perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable.
- BREVIBLOC is also indicated in noncompensatory sinus tachycardia where, in the physician’s judgment, the rapid heart rate requires specific intervention.
- BREVIBLOC is intended for short-term use.
Intraoperative and Postoperative Tachycardia and/or Hypertension
BREVIBLOC (Esmolol Hydrochloride) is indicated for the short-term treatment of tachycardia and hypertension that occur during induction and tracheal intubation, during surgery, on emergence from anesthesia and in the postoperative period, when in the physician’s judgment such specific intervention is considered indicated.
Use of BREVIBLOC to prevent such events is not recommended.[1]
References
Adapted from the FDA Package Insert.